Prescription Required
Formulation: Capsule
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Capsule
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Mycobutin is a prescription antibiotic primarily used to prevent certain serious bacterial infections in people with advanced HIV infection. It may also be prescribed as part of combination antibiotic treatment for selected mycobacterial infections.
It contains rifabutin, an active ingredient that helps stop bacteria from growing and multiplying by interfering with their ability to produce RNA, a substance needed for normal bacterial function.
Mycobutin belongs to a class of antibiotics called rifamycins. These medications work against certain types of bacteria, particularly mycobacteria, which can cause infections such as tuberculosis (TB) and Mycobacterium avium complex (MAC) disease.
Mycobutin is specifically approved to help prevent disseminated MAC disease in patients with advanced HIV infection. Disseminated infection means that the bacteria have spread beyond one area of the body and may affect several organs.
Rifabutin may also be used alongside other antibiotics to treat certain MAC infections or active tuberculosis, depending on the patient’s medical condition and treatment needs.
Mycobutin is not used alone to treat active tuberculosis or MAC disease. Combination antibiotic treatment helps improve effectiveness and reduce the risk of bacterial resistance.
Mycobutin is indicated for the prevention of disseminated MAC disease in certain patients with advanced HIV infection.
MAC refers to a group of bacteria that includes Mycobacterium avium and related species.
These bacteria are commonly found in the environment, including soil, dust, and water.
Most people encounter these bacteria without developing serious illness because their immune systems can control the infection.
However, people with severely weakened immune systems may be more susceptible to MAC disease.
This is particularly important for individuals with advanced HIV infection who have very low CD4 cell counts.
CD4 cells are a type of white blood cell that helps the immune system recognize and fight infections.
When CD4 cell levels become extremely low, the body may have difficulty controlling certain bacteria.
MAC organisms may then spread through the bloodstream and infect multiple organs.
This is called disseminated MAC disease.
Symptoms may include persistent fever, night sweats, fatigue, diarrhea, abdominal discomfort, anemia, and unexplained weight loss.
Mycobutin helps prevent MAC bacteria from multiplying, lowering the risk of developing disseminated infection.
However, preventive treatment is not necessary for every person with HIV.
Modern antiretroviral therapy (ART) can restore immune function and substantially reduce the risk of MAC disease.
Healthcare providers generally consider preventive MAC medication only for selected patients with severe immune suppression who are not receiving effective ART, after ruling out active MAC disease.
Mycobutin helps prevent disseminated MAC disease in certain high-risk patients with advanced HIV infection, but it does not treat HIV itself.
Mycobutin may also be prescribed as part of combination antibiotic treatment for established MAC infections.
MAC disease can affect different parts of the body, including the lungs, lymph nodes, and bloodstream.
Pulmonary MAC infection occurs when MAC bacteria affect the lungs.
This condition may be more common in people with chronic lung diseases, such as bronchiectasis or chronic obstructive pulmonary disease (COPD).
Symptoms may include a persistent cough, mucus production, fatigue, shortness of breath, fever, and weight loss.
Patients with advanced immune suppression may develop disseminated MAC disease, which affects several organs.
Treatment usually requires a combination of antibiotics because MAC bacteria can be difficult to eliminate.
Mycobutin may be used alongside medications such as azithromycin or clarithromycin and ethambutol, depending on the infection and treatment guidelines.
Rifabutin is not suitable for every MAC treatment regimen, and its use must account for interactions with other medications.
The treatment period may be lengthy, particularly in patients with pulmonary or disseminated MAC infections.
Mycobutin may help treat certain MAC infections when combined with other appropriate antibiotics, but it should not be used alone because bacterial resistance can develop.
Mycobutin may also be used as part of combination antibiotic treatment for active tuberculosis.
Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis.
It most commonly affects the lungs but may also involve the lymph nodes, kidneys, bones, brain, or other organs.
Common symptoms include a persistent cough, chest discomfort, fever, night sweats, fatigue, and unexplained weight loss.
Mycobutin helps control the infection by preventing tuberculosis bacteria from producing the RNA they need to grow and multiply.
However, Mycobutin is not generally the first rifamycin antibiotic selected for tuberculosis treatment.
Rifampin is commonly used in standard tuberculosis treatment regimens.
Mycobutin may be considered as an alternative in certain circumstances, particularly when rifampin has significant interactions with other necessary medications.
This can be important for patients with HIV who take antiretroviral medications.
Mycobutin may have fewer interactions than rifampin with some antiretroviral drugs, although important interactions can still occur.
In selected circumstances, it may also be used for tuberculosis caused by bacteria shown through laboratory testing to be susceptible to rifabutin.
However, resistance to rifampin does not automatically mean that rifabutin will be effective.
Your healthcare provider will select an appropriate combination of antibiotics based on susceptibility testing, medical history, and other medications.
Mycobutin may be used to treat selected cases of tuberculosis, but it must be combined with other effective antibiotics to prevent the development of drug resistance.
Mycobutin contains rifabutin, an antibiotic that interferes with the bacteria’s ability to produce RNA.
RNA is a substance that helps cells use genetic information to produce proteins needed for survival and growth.
Bacteria rely on an enzyme called DNA-dependent RNA polymerase to produce RNA.
Mycobutin blocks this enzyme in susceptible bacteria.
Without normal RNA production, the bacteria cannot produce essential proteins or carry out normal cellular functions.
This interferes with bacterial growth and can lead to bacterial death.
Blocks Bacterial RNA Production
Mycobutin attaches to bacterial RNA polymerase and prevents it from functioning normally.
This stops bacteria from producing the RNA necessary for making essential proteins.
As a result, susceptible bacteria lose their ability to function and multiply.
Helps Control Mycobacterial Infections
Mycobutin is active against certain mycobacteria, including organisms responsible for MAC disease and susceptible tuberculosis infections.
By preventing these bacteria from multiplying, Mycobutin helps reduce the risk of infection or supports treatment when combined with other appropriate antibiotics.
Helps Prevent Drug Resistance When Used Correctly
When treating an established mycobacterial infection, Mycobutin is generally used with other antibiotics.
Using several effective medications together helps reduce the likelihood that resistant bacteria will survive.
Taking Mycobutin alone to treat active tuberculosis can lead to resistance, potentially making future treatment more difficult.
Mycobutin works by blocking bacterial RNA production, helping prevent or control infections caused by susceptible mycobacteria.
Mycobutin begins acting against susceptible bacteria after treatment starts, but the time needed to experience noticeable benefits depends on why the medication is prescribed.
For patients taking Mycobutin to prevent MAC disease, there may be no noticeable change in how they feel.
This is because preventive treatment is intended to reduce the likelihood of developing an infection rather than relieve existing symptoms.
Patients receiving Mycobutin as part of treatment for an established mycobacterial infection may experience gradual improvements over several weeks.
Symptoms such as fever, fatigue, coughing, or night sweats may improve as the infection responds to treatment.
However, some mycobacterial infections require several months of antibiotic therapy.
The duration depends on the infection, the patient’s immune system, and the response to the complete treatment regimen.
Continue taking Mycobutin as prescribed, even if you feel well or your symptoms improve.
Mycobutin is available as oral capsules, commonly containing 150 mg of rifabutin.
The prescribed dose depends on whether the medication is being used to prevent MAC disease or as part of treatment for an established infection.
Possible side effects include nausea, abdominal discomfort, rash, changes in blood cell counts, and liver-related problems.
Mycobutin may also cause orange-brown discoloration of urine, sweat, tears, and other body fluids. This effect is usually harmless, but it can permanently stain soft contact lenses.
An important potential complication is uveitis, which is inflammation inside the eye.
Symptoms may include eye pain, redness, sensitivity to light, or blurred vision.
Seek prompt medical attention if you develop eye pain, redness, light sensitivity, or changes in eyesight while taking Mycobutin.
Mycobutin also interacts with several medications, including certain antiretroviral drugs, antifungal medications, and antibiotics.
Some combinations require dosage adjustments, while others should be avoided entirely.
Before starting treatment, tell your healthcare provider about all medications and supplements you take.
Mycobutin’s approved indication in the United States and Canada is the prevention of disseminated MAC disease in patients with advanced HIV infection. Other uses, including certain treatment regimens for MAC and tuberculosis, depend on clinical guidelines, susceptibility results, and applicable local approvals.
Mycobutin should be used only under the supervision of a healthcare provider experienced in managing mycobacterial infections.Â
Mycobutin is a prescription antibiotic used to help prevent certain serious bacterial infections in people with advanced HIV infection. It may also be prescribed alongside other antibiotics to treat selected mycobacterial infections, including Mycobacterium avium complex (MAC) disease and tuberculosis (TB).
It contains rifabutin, an antibiotic that helps stop susceptible bacteria from growing and multiplying.
Mycobutin is available as an oral capsule, commonly containing 150 mg of rifabutin.
The medication is usually taken once daily when prescribed to prevent MAC disease. However, different dosing schedules may be recommended when treating an active infection or when Mycobutin is combined with certain other medications.
Mycobutin can be taken with or without food. If you experience nausea or stomach discomfort, taking the capsules with a meal may help.
Your healthcare provider will determine the appropriate dosage based on your medical condition, treatment purpose, other medications, and response to therapy.
Take Mycobutin exactly as prescribed. Do not increase your dosage, skip doses, or stop treatment without consulting your healthcare provider.
Mycobutin capsules are taken by mouth according to your healthcare provider’s instructions.
Swallow the capsules with a glass of water. Follow your pharmacist’s instructions if you have difficulty swallowing them.
You may take Mycobutin with or without food.
If the medication causes an upset stomach, taking it with a meal may improve tolerability.
Follow the dosage and frequency stated on your prescription label.
If Mycobutin is prescribed once daily, try to take it at approximately the same time each day.
If your healthcare provider prescribes divided doses or a different schedule, follow those instructions carefully.
Because Mycobutin can interact with several medications, your dosing schedule may need to be adjusted when certain antibiotics, antifungal medications, or HIV treatments are used.
Always follow your prescribed dosing schedule rather than changing how often you take Mycobutin on your own.
The recommended dosage of Mycobutin depends on the condition being treated and other medications you are taking.
For adults receiving Mycobutin to prevent disseminated MAC disease, the usual recommended dose is 300 mg once daily.
This is equivalent to two 150 mg capsules taken together.
If patients experience significant nausea, vomiting, or other gastrointestinal discomfort, a healthcare provider may recommend taking 150 mg twice daily with food.
However, this adjustment should only be made under medical supervision.
When Mycobutin is used as part of treatment for active MAC infection or tuberculosis, the dosage may differ.
Certain medications can increase or decrease rifabutin concentrations in the bloodstream, making dose adjustments necessary.
Your healthcare provider may also consider your kidney function, liver function, and treatment response.
Do not assume that the same Mycobutin dosage is appropriate for every mycobacterial infection.
Yes. Mycobutin can generally be taken with or without food.
Food does not usually prevent the medication from working effectively.
However, Mycobutin may cause digestive side effects, including nausea, abdominal discomfort, vomiting, or diarrhea.
Taking the medication with a meal may help reduce these symptoms.
If you experience stomach discomfort, try taking your prescribed dose with food unless your healthcare provider has given different instructions.
Tell your healthcare provider if nausea or vomiting becomes persistent or prevents you from taking your medication.
Taking Mycobutin with food may help reduce stomach discomfort, but it is not required for every patient.
Mycobutin can generally be taken at a time that fits your prescribed treatment schedule.
For patients taking Mycobutin once daily, choosing a consistent time may help prevent missed doses.
For example, you may take your medication every morning with breakfast.
Taking the medication at approximately the same time each day helps establish a regular routine.
If Mycobutin is prescribed twice daily, your healthcare provider may recommend spacing the doses approximately 12 hours apart.
However, some patients require different schedules because of medication interactions or specific treatment regimens.
If you take several medications for HIV or another infection, ask your healthcare provider or pharmacist whether they should be taken together or at different times.
The most important factor is taking Mycobutin consistently according to your prescribed dosing schedule.
Taking Mycobutin consistently helps maintain its effectiveness against susceptible mycobacteria.
Mycobacterial infections can be difficult to treat because the bacteria may grow slowly and survive in the body for extended periods.
When Mycobutin is prescribed to prevent MAC disease, regular use helps reduce the risk of developing a serious infection.
When it is used to treat an established infection, it works alongside other antibiotics to control bacterial growth.
Missing doses may reduce treatment effectiveness.
For active infections, repeatedly skipping doses or stopping treatment too early may allow bacteria to survive and increase the risk of antibiotic resistance.
Drug-resistant infections can be more difficult to treat and may require different medications or longer treatment.
To help remember your doses, consider using a medication calendar, phone alarm, or pill organizer.
Continue taking Mycobutin as prescribed, even if you feel well or your symptoms have improved.
If you forget to take Mycobutin, take the missed dose as soon as you remember, unless it is almost time for your next scheduled dose.
If your next dose is approaching, skip the missed dose and continue with your regular schedule.
Do not take two doses at the same time to make up for a missed dose.
Taking extra Mycobutin may increase the risk of nausea, vomiting, liver-related problems, and other side effects.
If you are taking Mycobutin as part of combination treatment for an active infection, contact your healthcare provider if you miss a dose.
Your healthcare team may provide additional instructions to help maintain treatment effectiveness.
Do not double your Mycobutin dose to make up for a missed capsule.
The length of treatment depends on why Mycobutin was prescribed.
Patients taking Mycobutin to prevent MAC disease may need ongoing preventive treatment while they remain at significant risk of infection.
However, patients whose immune systems improve with effective HIV treatment may no longer require MAC preventive medication.
Your healthcare provider will review your CD4 cell count, response to antiretroviral therapy, and other medical factors before deciding whether to continue treatment.
For patients receiving Mycobutin as part of treatment for active tuberculosis or MAC disease, treatment may last several months or longer.
The exact duration depends on the infection, laboratory findings, and response to the complete antibiotic regimen.
Even if your symptoms improve, some bacteria may remain in your body.
Stopping treatment too early can allow an infection to return and may increase the risk of antibiotic resistance.
Continue taking Mycobutin for the full period prescribed by your healthcare provider.
Mycobutin may interact with several medications, including certain HIV treatments, antibiotics, antifungal medications, and hormonal contraceptives.
These interactions can affect the amount of rifabutin or another medication in your bloodstream.
For example, some medications can increase rifabutin concentrations, which may increase the risk of side effects.
Other medications may reduce rifabutin levels and potentially affect treatment effectiveness.
Mycobutin may also reduce the effectiveness of certain hormonal contraceptives. Your healthcare provider may recommend an additional or alternative nonhormonal method of contraception.
Patients receiving antiretroviral treatment for HIV require particular attention because several antiretroviral medications interact with rifabutin.
Your healthcare provider may need to adjust your medication regimen or recommend additional monitoring.
Tell your healthcare provider and pharmacist about every prescription medication, over-the-counter product, vitamin, and herbal supplement you use before starting Mycobutin.
The signs that Mycobutin is working depend on whether it is being used to prevent or treat an infection.
If you are taking Mycobutin to prevent disseminated MAC disease, you may not notice any change in how you feel.
This is because the medication is intended to reduce the risk of developing an infection rather than treat symptoms you already have.
If Mycobutin is being used to treat an established mycobacterial infection, your symptoms may gradually improve as the bacteria respond to treatment.
For example, you may experience fewer episodes of fever, improved energy, reduced coughing, or less nighttime sweating.
However, symptom improvement alone does not confirm that the infection has been eliminated.
Your healthcare provider may recommend blood tests, cultures, imaging studies, or other examinations to evaluate your response.
Continue taking Mycobutin as prescribed, even if you feel better or no longer have noticeable symptoms.
Mycobutin may cause side effects, including nausea, vomiting, abdominal discomfort, and changes in blood cell counts.
It can also cause urine, sweat, tears, and other body fluids to become orange or reddish-brown. This discoloration is usually harmless, but it may permanently stain soft contact lenses.
A serious potential side effect is uveitis, which causes inflammation inside the eye.
Symptoms may include eye pain, redness, blurred vision, or sensitivity to light.
Contact your healthcare provider promptly if you notice eye pain, redness, or vision changes while taking Mycobutin.
Mycobutin may also affect liver function or blood cell counts, particularly when used with certain other medications.
Your healthcare provider may recommend laboratory testing during treatment.
Tell your healthcare provider immediately if you develop yellowing of the skin or eyes, unusual bruising, persistent fever, or other concerning symptoms.
Take Mycobutin exactly as prescribed, attend regular follow-up appointments, and do not stop or change your treatment without medical guidance.
The dosing information above is consistent with the official Mycobutin prescribing information, including the usual 300 mg once-daily dose for MAC prevention and the option of 150 mg twice daily with food for patients experiencing gastrointestinal discomfort.Â
Mycobutin (Rifabutin) is available in the following forms and strength:
Mycobutin should always be taken according to your healthcare provider’s instructions to reduce the risk of antibiotic resistance.
Antibiotic resistance occurs when bacteria develop changes that allow them to survive medications that would normally kill them or prevent their growth.
Mycobutin is used to prevent certain infections caused by Mycobacterium avium complex (MAC) and may also be prescribed with other antibiotics to treat selected mycobacterial infections.
When Mycobutin is used to treat active tuberculosis or MAC disease, it is generally combined with other appropriate antibiotics.
Taking Mycobutin alone for an active infection, repeatedly missing doses, or stopping treatment too early may increase the risk of resistant bacteria developing.
Drug-resistant infections can be more difficult to treat and may require different medications or longer treatment periods.
Take Mycobutin exactly as prescribed and do not stop treatment early, even if your symptoms improve.
Mycobutin may interact with several prescription medications, over-the-counter products, and herbal supplements.
These interactions can change the amount of medication circulating in the bloodstream.
Some medications may increase rifabutin levels, raising the risk of side effects. Others may reduce its effectiveness or become less effective when taken with Mycobutin.
For example, Mycobutin may interact with certain anticoagulants, HIV medications, antifungal medications, and antibiotics.
Rifabutin affects an enzyme called CYP3A, which helps the body process many medications.
By increasing the activity of this enzyme, Mycobutin can cause certain medications to break down more quickly.
Other medications that block CYP3A may increase rifabutin exposure.
Your healthcare provider may need to adjust your dosage, recommend another medication, or arrange additional monitoring.
Tell your healthcare provider and pharmacist about every medication, vitamin, and supplement you take before starting Mycobutin.
Do not start, stop, or change another medication without medical guidance.Â
Mycobutin may occasionally cause liver-related side effects.
The liver helps process medications and remove harmful substances from the body.
Rifabutin is mainly processed by the liver, where enzymes help break it down into substances that can be eliminated.
In some patients, rifabutin treatment may cause increased liver enzyme levels or liver injury.
The medical term for medication-related liver damage is hepatotoxicity.
Patients with existing liver disease may be more vulnerable to complications, particularly when Mycobutin is taken with other medications that can affect the liver.
Symptoms of liver problems may include unusual tiredness, persistent nausea, loss of appetite, upper abdominal discomfort, dark urine, or yellowing of the skin and eyes.
Yellowing of the skin or eyes is called jaundice and may indicate liver dysfunction.
Your healthcare provider may recommend liver function tests before or during treatment, especially if you have existing liver disease or take other potentially hepatotoxic medications.
Contact your healthcare provider promptly if you develop dark urine, yellowing of the skin or eyes, persistent vomiting, or other signs of liver injury.
Patients with kidney disease should inform their healthcare provider before taking Mycobutin.
Although rifabutin is primarily metabolized by the liver, kidney function can still affect medication exposure.
When kidney function is severely reduced, the body may have more difficulty removing certain medication-related substances.
This can increase the risk of side effects.
Patients with mild to moderate kidney impairment generally do not require routine dosage adjustments.
However, patients with severe kidney impairment may need additional monitoring or a reduced dosage.
Your healthcare provider may recommend kidney function tests to determine whether treatment adjustments are necessary.
Patients receiving dialysis or treatment for advanced kidney disease should also discuss their medical history with their healthcare provider.
Do not adjust your Mycobutin dosage on your own if you have kidney problems.
Your healthcare provider will determine whether any changes are necessary based on your kidney function and response to treatment.Â
Do not take Mycobutin if you are allergic to rifabutin or other rifamycin antibiotics.
Rifamycins are a group of antibiotics that includes rifabutin, rifampin, and rifapentine.
An allergic reaction occurs when the immune system responds to a medication or substance it mistakenly identifies as harmful.
Mild reactions may include itching, skin redness, or a rash.
More serious reactions may cause hives, swelling of the face or throat, difficulty breathing, or a sudden drop in blood pressure.
In rare cases, severe allergic reactions such as anaphylaxis may occur.
Anaphylaxis is a potentially life-threatening reaction that can develop rapidly and interfere with normal breathing or circulation.
Tell your healthcare provider if you have experienced an allergic reaction to any rifamycin antibiotic in the past.
Stop taking Mycobutin and seek emergency medical attention if you experience difficulty breathing, swelling of the face or throat, or other signs of a severe allergic reaction.
QT prolongation is a condition in which the heart’s electrical system takes longer than normal to recover between heartbeats.
It can increase the risk of certain dangerous heart rhythm disturbances, particularly in people with existing risk factors.
However, QT prolongation is not a well-established direct side effect of Mycobutin.
This warning is more relevant when rifabutin is combined with certain other medications that can affect heart rhythm.
Some antibiotics, including particular macrolides, may prolong the QT interval.
Because Mycobutin is sometimes used with macrolide antibiotics to treat mycobacterial infections, your healthcare provider may need to assess your overall risk.
Tell your healthcare provider if you have a history of abnormal heart rhythms, fainting, heart disease, or electrolyte imbalances.
Your healthcare provider may recommend additional monitoring if you take medications that affect the heart’s electrical activity.
Seek immediate medical attention if you experience fainting, a persistent irregular heartbeat, or severe dizziness accompanied by chest discomfort.
Mycobutin may cause gastrointestinal side effects, including nausea, vomiting, abdominal discomfort, and diarrhea.
These symptoms may occur because antibiotics can affect the digestive system and the natural balance of bacteria in the intestines.
Mild nausea or stomach discomfort may improve as your body adjusts to treatment.
Taking Mycobutin with food may help reduce digestive symptoms.
Some patients who experience significant nausea may be prescribed divided doses by their healthcare provider.
However, do not change your dosage or dosing schedule without medical advice.
In rare cases, antibiotic treatment may cause a more serious intestinal infection associated with Clostridioides difficile (C. difficile).
This infection can cause severe or persistent diarrhea, abdominal cramping, and fever.
Symptoms may develop during antibiotic treatment or even several weeks after treatment has ended.
Contact your healthcare provider promptly if you experience severe diarrhea, bloody stools, persistent vomiting, or significant abdominal pain.
Do not use medications to stop severe diarrhea unless your healthcare provider recommends them.Â
Mycobutin must be used carefully when treating infections caused by Mycobacterium tuberculosis or other mycobacteria.
These bacteria can develop resistance when exposed to antibiotics without an effective combination treatment regimen.
Rifabutin is not generally recommended as the only antibiotic for treating active tuberculosis.
When Mycobutin is prescribed for active tuberculosis, it should be combined with other effective antituberculosis medications.
Your healthcare provider may use laboratory testing to determine which antibiotics are most likely to work against the infection.
If the bacteria are resistant to certain antibiotics, a different treatment regimen may be needed.
Resistance to rifampin, another rifamycin antibiotic, may also affect how well rifabutin works.
However, rifampin resistance does not always mean that rifabutin will be ineffective. Laboratory testing may help determine susceptibility.
Never use Mycobutin alone to treat active tuberculosis or an established MAC infection unless a specialist has specifically directed an appropriate treatment plan.
Mycobutin may occasionally cause thrombocytopenia, a condition in which the number of platelets in the bloodstream becomes unusually low.
Platelets are small blood cells that help the body form clots and stop bleeding after an injury.
When platelet levels decrease, the body may have difficulty controlling bleeding.
Symptoms may include unexplained bruising, frequent nosebleeds, bleeding gums, or small red or purple spots beneath the skin.
Some patients may also notice prolonged bleeding after minor cuts.
In severe cases, thrombocytopenia can increase the risk of serious bleeding.
Mycobutin may also affect white blood cell counts, particularly neutrophils, which help the body fight infections.
A low neutrophil count is called neutropenia.
Your healthcare provider may recommend periodic blood tests to monitor your blood cell counts during treatment.
Contact your healthcare provider promptly if you develop unusual bruising, unexplained bleeding, persistent fever, or signs of infection.
Seek emergency medical attention if you experience severe bleeding or bleeding that does not stop.Â
Mycobutin has been associated with uveitis, a condition that causes inflammation inside the eye.
The uvea is the middle layer of the eye and includes structures involved in supplying blood and controlling how light enters the eye.
When the uvea becomes inflamed, patients may experience eye pain, redness, blurred vision, or increased sensitivity to light.
Some patients may notice floating spots or other visual disturbances.
The risk of uveitis may increase when rifabutin levels become elevated.
This can occur when Mycobutin is taken with certain medications, including clarithromycin or fluconazole.
These medications may interfere with the body’s ability to process rifabutin, increasing exposure to the antibiotic.
Your healthcare provider may adjust your medication regimen or recommend additional monitoring when these combinations are necessary.
Uveitis requires prompt medical evaluation because untreated inflammation can lead to complications affecting vision.
Contact your healthcare provider immediately if you develop eye pain, redness, light sensitivity, blurred vision, or other new vision changes.
Your healthcare provider may refer you to an eye specialist for further examination.Â
Mycobutin may cause skin reactions, including redness, itching, hives, or a rash.
Some reactions are mild, while others may indicate an allergy to the medication.
Hives, also called urticaria, appear as raised, itchy patches on the skin.
Although many skin reactions are not serious, certain symptoms may indicate a more severe condition.
Rarely, rifamycin antibiotics have been associated with serious skin reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
These conditions can cause painful skin inflammation, blistering, peeling, and sores affecting the mouth, eyes, or other mucous membranes.
A severe skin reaction may begin with flu-like symptoms, such as fever, tiredness, or body aches.
If you develop a new rash while taking Mycobutin, contact your healthcare provider promptly.
Stop taking Mycobutin and seek emergency medical attention if you develop blistering skin, peeling, painful mouth sores, or a widespread rash accompanied by fever.
Patients with HIV who take Mycobutin require careful monitoring because rifabutin may interact with several antiretroviral medications.
Antiretroviral therapy (ART) helps control HIV by reducing the amount of virus in the bloodstream.
Some antiretroviral medications affect liver enzymes responsible for processing rifabutin.
As a result, certain combinations may increase rifabutin levels and the risk of side effects.
Other combinations may reduce the effectiveness of the antiretroviral medication.
For example, some HIV protease inhibitors can increase rifabutin exposure, while rifabutin may reduce concentrations of certain other HIV medications.
Depending on the specific combination, your healthcare provider may recommend dosage adjustments, additional monitoring, or an alternative treatment.
Not every HIV medication can be safely combined with Mycobutin.
Tell your healthcare provider about your complete HIV treatment regimen before starting Mycobutin.
Do not change or stop your antiretroviral medications without consulting your HIV treatment team.Â
Grapefruit and grapefruit juice can interact with certain medications by affecting enzymes involved in drug metabolism.
One of these enzymes is called CYP3A4, which helps process rifabutin and many other medications.
Grapefruit can inhibit CYP3A4 activity in the intestine, causing some medications to reach higher concentrations in the bloodstream.
However, a clinically significant interaction between grapefruit and Mycobutin has not been clearly established.
Mycobutin’s prescribing information does not identify grapefruit as a specific contraindication.
Nevertheless, patients taking Mycobutin often use several other medications, including antiretroviral drugs, which may have their own grapefruit-related interactions.
For this reason, it is important to consider your complete medication regimen rather than Mycobutin alone.
Ask your healthcare provider or pharmacist whether grapefruit and grapefruit juice are appropriate with your prescribed medications.Â
Mycobutin is used to prevent certain serious MAC infections and may also be prescribed with other antibiotics to treat selected mycobacterial infections.
The medication requires careful monitoring because it can interact with other treatments and occasionally cause serious side effects.
Your healthcare provider may recommend periodic blood tests to evaluate your liver function, kidney function, and blood cell counts.
Mycobutin may also cause orange-brown discoloration of urine, sweat, tears, saliva, and other body fluids. This effect is usually harmless, but it may permanently stain soft contact lenses.
Report any unusual side effects, particularly eye pain, changes in vision, persistent fever, unusual bruising, severe diarrhea, or signs of liver problems.
Seek immediate medical attention if you experience severe allergic reactions, uncontrolled bleeding, serious skin reactions, or significant eye symptoms.
Continue taking Mycobutin exactly as prescribed and attend regular follow-up appointments to help ensure that your treatment remains safe and effective.
If you forget to take a dose of Mycobutin, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at the same time to make up for a missed capsule. Taking more Mycobutin than prescribed may increase the risk of side effects, including nausea, vomiting, and other unwanted reactions. Missing doses repeatedly may also reduce the effectiveness of treatment, particularly when Mycobutin is used alongside other antibiotics to treat an active mycobacterial infection. To help prevent missed doses, take Mycobutin at approximately the same time each day. You may also consider using a medication reminder or calendar. Never double your Mycobutin dose to make up for a missed dose. If you miss several doses or are unsure how to continue your treatment, contact your healthcare provider or pharmacist for guidance.
Yes. Mycobutin can be taken with or without food, depending on your preference and how well you tolerate the medication. Some patients may experience digestive side effects, including nausea, vomiting, or abdominal discomfort, particularly when starting treatment. Taking Mycobutin with a meal may help reduce stomach irritation and make the medication easier to tolerate. If you experience significant stomach discomfort, your healthcare provider may recommend adjusting how your prescribed daily dose is divided. However, do not change your dosage or dosing schedule without medical advice. Taking Mycobutin with food may help reduce nausea and stomach discomfort. Contact your healthcare provider if digestive symptoms become severe, persistent, or interfere with your ability to take the medication.
Yes. Mycobutin can interact with several medications, including anticoagulants, certain HIV medications, antibiotics, antifungal medications, and hormonal contraceptives. Mycobutin affects liver enzymes that help process many medications. This can change how quickly some drugs are broken down and removed from the body. As a result, certain medications may become less effective, while others may increase rifabutin levels and the risk of side effects. For example, some antiretroviral medications used to treat HIV can interact with Mycobutin and may require dosage adjustments or additional monitoring. Certain antifungal medications and antibiotics, including clarithromycin, may increase rifabutin exposure and raise the risk of complications such as uveitis, an inflammation inside the eye. Mycobutin may also reduce the effectiveness of some hormonal contraceptives, making additional or alternative contraception necessary. Tell your healthcare provider and pharmacist about all prescription medications, over-the-counter products, vitamins, and herbal supplements you take. Do not start, stop, or change another medication without medical guidance.
Grapefruit and grapefruit juice can affect how certain medications are processed by the body. However, a clinically significant interaction between grapefruit and Mycobutin has not been clearly established. Mycobutin contains rifabutin, which is processed partly by a liver enzyme called CYP3A4. This enzyme helps break down many medications so they can be removed from the body. Grapefruit contains substances that can interfere with CYP3A4 activity in the intestines. For some medications, this may increase the amount of the drug entering the bloodstream and raise the risk of side effects. Although grapefruit is not specifically listed as a contraindication in Mycobutin’s prescribing information, caution may be appropriate because rifabutin can interact with other medications. This is particularly important for patients who take Mycobutin alongside HIV medications, antifungal treatments, or other drugs affected by grapefruit. Ask your healthcare provider or pharmacist whether grapefruit and grapefruit juice are safe with your complete medication regimen. Avoid grapefruit if any of your other prescribed medications have a known grapefruit interaction.Â
| Generic name: | Rifabutin |
|---|---|
| Formulation: | Capsule |
| Strength(s): | 150mg |
| Quantities Available: | 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Mycobutin (rifabutin) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Mycobutin is commonly prescribed in a dosage of 150 mg, taken once or twice daily depending on the severity of the condition and your healthcare provider’s instructions. For a 90-day supply, this means you would order 90 to 180 capsules (90 days x 1 to 2 capsules per day).
No, we do not sell rifabutin directly on our website. However, you can still enjoy low prices on Mycobutin, which contains rifabutin as an active ingredient. To purchase Mycobutin, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Mycobutin (rifabutin) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Mycobutin (Rifabutin). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Mycobutin (Rifabutin).
REVIEWS